Oct 31, 2024 / 08:30PM GMT
Operator
Hello, welcome to Veer Biotechnologies third quarter, 2024 financial results and business update call as a reminder, this conference call is being recorded at this time. All participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. If you would like to ask a question during this time, simply press the star key followed by the number one on your telephone keypad. If you would like to withdraw your question, press star one again and then I'll turn the call over to Rich Lepke, Senior Director, Investor Relations. You may begin Mr Lepke.
Richard Lepke - Vir Biotechnology Inc - Senior Director of Investor Relations
Thank you. And good afternoon with me today are Dr Marianne De Backer, our Chief Executive Officer, Dr Mark Eisner, our Chief Medical Officer, and Jason o'byrne, our Chief Financial Officer.
Before we begin, I would like to remind everyone that some of the statements we are making today are forward-looking statements under the securities laws. These forward-looking statements involve
Q3 2024 Vir Biotechnology Inc Earnings Call Transcript
Nov 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers